Silver(<scp>i</scp>) complexes bearing heterocyclic thioamide ligands with NH<sub>2</sub> and CF<sub>3</sub> substituents: effect of ligand group substitution on antibacterial and anticancer properties-Reference-Cited by-同舟云学术

Silver(i) complexes bearing heterocyclic thioamide ligands with NH₂ and CF₃ substituents: effect of ligand group substitution on antibacterial and anticancer properties

Published:2022 Issue:24 Volume:51 Page:9412-9431
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Varna Despoina¹,Geromichalou Elena²,Hatzidimitriou Antonios G.¹,Papi Rigini³,Psomas George¹^ORCID,Dalezis Panagiotis²^ORCID,Aslanidis Paraskevas¹,Choli-Papadopoulou Theodora³,Trafalis Dimitrios T.²^ORCID,Angaridis Panagiotis A.¹^ORCID

Affiliation:

1. Laboratory of Inorganic Chemistry, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece

2. Laboratory of Pharmacology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece

3. Laboratory of Biochemistry, Department of Chemistry, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece

Abstract

Silver(i) complexes with NH2- and CF3-substituted thioamide ligands were synthesized, with the former exhibiting higher in vitro antibacterial and cytotoxic potency.

Funder

State Scholarships Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/DT/D2DT00793B

Reference102 articles.

1. Cisplatin in cancer therapy: Molecular mechanisms of action

2. Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy (Eur. J. Inorg. Chem. 20/2006)

3. Metallodrugs are unique: opportunities and challenges of discovery and development